Michael A. Derby

1.8k total citations
31 papers, 1.5k citations indexed

About

Michael A. Derby is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Michael A. Derby has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Michael A. Derby's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and HIV Research and Treatment (4 papers). Michael A. Derby is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and HIV Research and Treatment (4 papers). Michael A. Derby collaborates with scholars based in United States, France and Canada. Michael A. Derby's co-authors include Jay A. Berzofsky, Martha A. Alexander‐Miller, John E. Pintar, Igor M. Belyakov, Jeffrey D. Ahlers, Brian L. Kelsall, Patricia L. Earl, Bernard Moss, Warren Strober and Klaus Früh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Michael A. Derby

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Derby United States 19 759 447 374 240 208 31 1.5k
Olaf Rosorius Germany 19 461 0.6× 871 1.9× 192 0.5× 117 0.5× 188 0.9× 24 1.4k
Theresa Higgins United Kingdom 19 527 0.7× 808 1.8× 283 0.8× 237 1.0× 105 0.5× 27 1.5k
Claudine Pique France 30 1.8k 2.4× 560 1.3× 164 0.4× 168 0.7× 135 0.6× 66 2.5k
Nicholas M. Stamatos United States 19 385 0.5× 658 1.5× 114 0.3× 141 0.6× 126 0.6× 23 1.1k
Alberto Fraile‐Ramos Spain 20 406 0.5× 500 1.1× 702 1.9× 78 0.3× 131 0.6× 23 1.4k
Brian M. Sullivan United States 18 954 1.3× 371 0.8× 424 1.1× 225 0.9× 93 0.4× 31 1.9k
Julien Burlaud‐Gaillard France 21 293 0.4× 578 1.3× 346 0.9× 147 0.6× 110 0.5× 66 1.9k
Kenia de los Santos United States 11 1.3k 1.7× 478 1.1× 193 0.5× 204 0.8× 87 0.4× 11 1.9k
Lucinda Hensley United States 20 610 0.8× 618 1.4× 359 1.0× 91 0.4× 66 0.3× 27 1.9k
Nathalie Sol‐Foulon France 19 904 1.2× 403 0.9× 299 0.8× 1.0k 4.3× 100 0.5× 29 1.8k

Countries citing papers authored by Michael A. Derby

Since Specialization
Citations

This map shows the geographic impact of Michael A. Derby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Derby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Derby more than expected).

Fields of papers citing papers by Michael A. Derby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Derby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Derby. The network helps show where Michael A. Derby may publish in the future.

Co-authorship network of co-authors of Michael A. Derby

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Derby. A scholar is included among the top collaborators of Michael A. Derby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Derby. Michael A. Derby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derby, Michael A., et al.. (2024). Infections and Patient Satisfaction in WALANT Hand Surgery in a Hospital Procedure Room. Hand. 21(1). 56–62. 1 indexed citations
2.
Hough, David M., Alice R. Mao, Michael G. Aman, et al.. (2023). Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder. Annals of General Psychiatry. 22(1). 45–45. 4 indexed citations
3.
Deng, Rong, Mauricio Maia, Jeremy J. Lim, et al.. (2017). Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial. Clinical Pharmacokinetics. 57(3). 367–377. 22 indexed citations
4.
5.
Ishida, Julie H., Anita Patel, Aneesh K. Mehta, et al.. (2016). Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrobial Agents and Chemotherapy. 61(2). 75 indexed citations
6.
Ishida, Julie H., Tracy Burgess, Michael A. Derby, et al.. (2015). Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults. Antimicrobial Agents and Chemotherapy. 59(8). 4919–4929. 33 indexed citations
7.
Zhang, Lu, Jill Chappell, Celedon Gonzales, et al.. (2007). QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study. Journal of Cardiovascular Pharmacology. 49(3). 146–153. 52 indexed citations
8.
Derby, Michael A., Lu Zhang, Celedon Gonzales, et al.. (2007). The Effects of Supratherapeutic Doses of Duloxetine on Blood Pressure and Pulse Rate. Journal of Cardiovascular Pharmacology. 49(6). 384–393. 30 indexed citations
9.
Derby, Michael A., Celedon Gonzales, Jill Chappell, et al.. (2005). QT interval analyses from a placebo and positive controlled study evaluating the electrophysiological effects of duloxetine at supratherapeutic doses. Clinical Pharmacology & Therapeutics. 77(2). P12–P12. 2 indexed citations
10.
Derby, Michael A., et al.. (2001). High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL. The Journal of Immunology. 166(3). 1690–1697. 173 indexed citations
11.
Chung, Doo Hyun, Igor M. Belyakov, Michael A. Derby, et al.. (2001). Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody. The Journal of Immunology. 167(2). 699–707. 8 indexed citations
12.
Derby, Michael A., Jian Wang, David H. Margulies, & Jay A. Berzofsky. (2001). Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. International Immunology. 13(6). 817–824. 55 indexed citations
13.
White, Jeffrey D., Gilian Wharfe, Donn M. Stewart, et al.. (2001). The Combination of Zidovudine and Interferon AIpha-2B in the Treatment of Adult T-Cell Leukemia/Lymphoma. Leukemia & lymphoma. 40(3-4). 287–294. 55 indexed citations
14.
Derby, Michael A., et al.. (2001). An abrupt and concordant initiation of apoptosis: antigen-dependent death of CD8+ CTL. European Journal of Immunology. 31(10). 2951–2959. 23 indexed citations
15.
Suh, Woong‐Kyung, Michael A. Derby, Myrna F. Cohen-Doyle, et al.. (1999). Interaction of Murine MHC Class I Molecules with Tapasin and TAP Enhances Peptide Loading and Involves the Heavy Chain α3 Domain. The Journal of Immunology. 162(3). 1530–1540. 69 indexed citations
16.
Ahlers, Jeffrey D., et al.. (1999). Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunological Reviews. 170(1). 151–172. 80 indexed citations
17.
Derby, Michael A., Myrna F. Cohen-Doyle, Gary J. Schoenhals, et al.. (1999). Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.. PubMed. 162(3). 1530–40. 75 indexed citations
18.
Belyakov, Igor M., Michael A. Derby, Jeffrey D. Ahlers, et al.. (1998). Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proceedings of the National Academy of Sciences. 95(4). 1709–1714. 231 indexed citations
19.
20.
Derby, Michael A.. (1978). Analysis of glycosaminoglycans within the extracellular environments encountered by migrating neural crest cells. Developmental Biology. 66(2). 321–336. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olaf Rosorius Breakdown of academic impact, for papers by Theresa Higgins Breakdown of academic impact, for papers by Claudine Pique Breakdown of academic impact, for papers by Nicholas M. Stamatos Breakdown of academic impact, for papers by Alberto Fraile‐Ramos Breakdown of academic impact, for papers by Brian M. Sullivan Breakdown of academic impact, for papers by Julien Burlaud‐Gaillard Breakdown of academic impact, for papers by Kenia de los Santos Breakdown of academic impact, for papers by Lucinda Hensley Breakdown of academic impact, for papers by Nathalie Sol‐Foulon
Rankless by CCL
2026